Page results
-
RESPOND is a new rapid access, community-based screening and care planning system for all asylum-seeking families registered with a GP in North Central London.
-
We wanted to let you know that Michelle and Sam at DigiBete will be doing a couple of online training sessions to help you set up your school care plan.
-
This page aims to support and supplement the information provided in the video titled Managing the Emotional Impact of Cancer, available on uclh.nhs.uk/wellbeing.
-
Information for relatives following bereavement and about the role of the Medical Examiner Service at UCLH.
-
Patient information about the Cognitive Behavioural Therapy for Insomnia (CBTi) at the RLHIM.
-
The LTFU service caters primarily for young people and adults treated in the paediatric cancer service at Great Ormond Street Hospital (GOSH), and young people and adults treated in the Teenage and Young Adult service at University College Hospital.
-
The UCLH Bariatric Centre for Weight Management and Metabolic Surgery is one of the largest obesity and bariatric centres in the county, with an international reputation for the quality and expertise of our clinical service, our research and the clinical training that we provide.
-
Advice on activity management for young people living with fatigue conditions.
-
Stroke services at UCLH provide the best possible clinical care for all phases of the stroke pathway.
-
This page provides information on giving babies vitamin K shortly after they are born.
File results
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab